Methods 56 patients with IR and fat metabolism disorder were randomly given oral dimethyldiguanide (group A) and Gliclazide capsule (group B) for 3 months.

• 方法将符合IR及脂代谢紊乱诊断的2型糖尿病患者56例随机分别予口服二甲双胍(A组)、格列齐特(B组)治疗3个月。